Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. They combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of Bloomlife's solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events, the company aims to ensure every family gets a healthy start.

Over the past 18 months, Bloomlife has built a unique data asset in maternal health, which powers their Prenatal Atlas platform for risk stratification and biomarker discovery. Through a direct-to-mom pregnancy wearable, they aggregated the richest physiological dataset in the world linked to birth outcomes both in high-risk and low-risk moms. These data include clinical-grade physiological data on maternal and fetal health and real-world evidence on birth outcomes covering more than 10,000 pregnancies. The company's first digital biomarker for (preterm) labor detection has been clinically validated with results presented at the Society for Maternal-Fetal Medicine and World Congress for Maternal-Fetal Neonatal Medicine.

Bloomlife has been recognized for its revolutionary vision and potential to impact lives globally, most recently receiving innovation awards and grants from Johnson & Johnson’s First 1000 Days Quick Fire Challenge, Fast Company World Changing Ideas, Maternal and Child Health Bureau, National Science Foundation, and the European Commission Horizon 2020 Initiative.